仙乐健康：2025年上半年，公司优势剂型占比提升，产品结构优化，实现公司整体毛利率提升

Core Insights - The company, Xianle Health, indicated that by the first half of 2025, the proportion of its advantageous dosage forms will increase, leading to an overall improvement in gross profit margin due to product structure optimization [1] - The gross profit margin and sales ratio of gummy products have both seen a year-on-year increase, while the competitive edge and profitability of soft capsules are expected to enhance as the business scales up [1] Group 1 - The company is implementing lean production and continuous cost reduction strategies, including supplier integration and negotiation, global procurement, and the promotion of preferred materials to achieve systematic cost reductions [1] - The introduction of an intelligent flexible production scheduling system and the establishment of a dynamic capacity matching mechanism have improved equipment and personnel utilization [1] - Continuous efforts to enhance production stability and process improvements have led to reduced material consumption and increased production line efficiency [1] Group 2 - The company is promoting the localization of spare parts to lower manufacturing costs [1]